COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES MEDIATED BY TLR4, IL1R, COX1/2 AND/OR RBP4

Patent number:

EP22382696

No items found.

The present invention refers to the medical field. Particularly, the present invention refers to a composition for use in the prevention and/or treatment of diseases mediated by TLR4, IL1R, COX1/2 and/or RBP4, preferably inflammatory diseases such as, for example, Osteoarthritis (OA) or other diseases, such as infectious diseases, causing an inflammatory response.

Countries:

Spain

Regions:

Galicia

Centers:

SERVIZO GALEGO DE SAUDE, INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA, OTHER

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

Currently there is no drug that blocks the TLR4 receptor and its associated responses, so this technology represents a disruptive change in the management of innate immunity and in the control of metabolic alterations dependent on the activation of TLR4 and IL1R receptors, the RBP4 protein, as well as the COX1/2 enzymes.

Comments

Other related patents

Health

METHOD AND SYSTEM FOR PREDICTING GLUCOSE VALUES AND ALERT GENERATION OF HYPOGLYCAEMIA AND HYPERGLYCEMIA (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries

Spain

Health

IN VITRO METHOD FOR SCREENING, DIAGNOSIS AND/OR PROGNOSIS OF COLORECTAL CANCER

Countries

Spain

Construction

Chemicals

Health

New & Sustainable Materials

Other

HYPERSPECTRAL IMAGE BASED ON DUAL-FREQUENCY COMB

Countries

Spain

Get back to patents directory